Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Lyra Therapeutics, Inc. (LYRA)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/25/2023 |
SC 13G
| Samsara BioCapital, L.P. reports a 5.6% stake in Lyra Therapeutics, Inc. |
| 06/12/2023 |
SC 13G
| CITADEL ADVISORS LLC reports a 5.9% stake in Lyra Therapeutics, Inc. |
| 02/14/2023 |
SC 13G
| Nantahala Capital Management, LLC reports a 7% stake in Lyra Therapeutics, Inc. |
| 11/08/2022 |
SC 13G
| PURA VIDA INVESTMENTS, LLC reports a 8.7% stake in Lyra Therapeutics, Inc. |
| 04/22/2022 |
SC 13G
| Venrock Healthcare Capital Partners II, L.P. reports a 10% stake in Lyra Therapeutics, Inc. |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/16/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/12/2021 |
SC 13G
| Polaris Venture Partners V, L.P. reports a 11% stake in Lyra Therapeutics, Inc. |
| 02/12/2021 |
SC 13G
| INTERSOUTH PARTNERS VII L P reports a 5.7% stake in Lyra Therapeutics, Inc. |
| 12/30/2020 |
SC 13G
| Ikarian Capital, LLC reports a 6.1% stake in Lyra Therapeutics, Inc. |
|
|